Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
D000179:Acrylates / Q000627:therapeutic use*; D000230:Adenocarcinoma / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003967:Diarrhea / Q000139:chemically induced; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D005334:Fever; D006261:Headache / Q000139:chemically induced; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012768:Shivering / Q000187:drug effects; D012877:Skin Manifestations; D013280:Stomatitis / Q000139:chemically induced; D013546:Sweating; D014581:Urticaria / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced; D014846:Vulvar Neoplasms / Q000188:drug therapy*
D000179:Acrylates; D000970:Antineoplastic Agents; D003520:Cyclophosphamide